Univest
Univest
  • Markets

Gujarat Themis Biosyn (GUJTHEM) Share Price Falls 7.71% to Rs 359.25 Today

  • September 9, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Gujarat Themis Biosyn Share Price
Gujarat Themis Biosyn (GUJTHEM) share price fell to Rs 359.25 today, down 7.71% from the previous close. Market cap was Rs 5,066.16 crore.

The Gujarat Themis Biosyn share price fell 7.71% on 16 November 2026, with the stock last trading at Rs 359.25 against the previous close of Rs 389.25, a fall of Rs 30 per share. At this level, Gujarat Themis Biosyn (GUJTHEM) carries a market capitalisation of Rs 5,066.16 crore and sits in the Mid Cap category, according to Univest data as of 16 November 2026 at 3:07:51 PM IST.

This Gujarat Themis Biosyn share price fall is the main market event for the stock today. The stock opened at Rs 377.70, touched a high of Rs 379.00 and a low of Rs 357.40, so the whole day range sits below the previous close. The sections below cover Gujarat Themis Biosyn share price today in detail, followed by the context around the move, valuation multiples, sector and peer comparison, and what investors can monitor next.

The Gujarat Themis Biosyn stock analysis shows a P/E ratio of 118.13 and a P/B ratio of 4.83, with ROE of 17.41% and ROCE of 18.16%. These figures frame the Gujarat Themis Biosyn share price update that follows.

Table of Contents

Toggle
  • Gujarat Themis Biosyn (GUJTHEM) Share Price Today: Price Action Analysis
  • Why Gujarat Themis Biosyn (GUJTHEM) May Be Moving Today
  • Gujarat Themis Biosyn (GUJTHEM) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching Gujarat Themis Biosyn
  • About Gujarat Themis Biosyn
  • Track Gujarat Themis Biosyn Share Price on Univest
  • Frequently Asked Questions
    • What is the Gujarat Themis Biosyn share price today?
    • How much has the Gujarat Themis Biosyn share price fallen today?
    • What is the market capitalisation of Gujarat Themis Biosyn?
    • What is the P/E ratio of Gujarat Themis Biosyn?
    • What are the ROE and ROCE of Gujarat Themis Biosyn?
    • What are the EPS and book value of Gujarat Themis Biosyn?
    • How does Gujarat Themis Biosyn compare with its peers?
    • Which sector and industry does Gujarat Themis Biosyn belong to?
    • What can investors monitor next for the Gujarat Themis Biosyn share price?

Gujarat Themis Biosyn (GUJTHEM) Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 359.25
Previous Close Rs 389.25
Today's Move -Rs 30.00 (-7.71%)
Open Rs 377.7
High Rs 379
Low Rs 357.4
Market Capitalisation Rs 5,066.16 crore
Market Cap Category Mid Cap

The Gujarat Themis Biosyn share price today stands at Rs 359.25, which is 7.71% below the previous close of Rs 389.25. The stock has lost Rs 30 per share, and its Rs 5,066.16 crore market capitalisation places it in the Mid Cap category. These figures are as of 16 November 2026 at 3:07:51 PM IST.

Looking at the day range, the Gujarat Themis Biosyn stock opened at Rs 377.70, which was already Rs 11.55 below the previous close. The day high of Rs 379.00 was only Rs 1.30 above the opening level, and the day low of Rs 357.40 is just Rs 1.85 below the current price. In other words, the Gujarat Themis Biosyn share price is trading close to the bottom of its range for the day, so the fall shows up in the percentage move and in the range itself. The next sections place this price action alongside the company’s reported context, fundamentals, valuation and peers.

Why Gujarat Themis Biosyn (GUJTHEM) May Be Moving Today

According to recent news reports, three second-quarter updates were published on 14 Nov at 3:28 pm IST and may be connected to today’s move in the Gujarat Themis Biosyn share price. EBITDA was reported at 177 million rupees against 209 million rupees a year earlier, with the EBITDA margin at 37.33% compared with 49.46%. Net profit was reported at 85 million rupees, down from 143 million rupees in the same period last year, while revenue rose to 474.5 million rupees from 423 million rupees. The mix of higher revenue with lower EBITDA, margin and net profit could be linked to the reaction in the stock, but the market data itself does not establish a single confirmed cause for the decline.

Gujarat Themis Biosyn (GUJTHEM) Fundamental Analysis

Metric Value
Market Capitalisation Rs 5,066.16 crore
P/E Ratio 118.13x
P/B Ratio 4.83x
ROE 17.41%
ROCE 18.16%
EPS Rs 3.3
Book Value Per Share Rs 80.59
Dividend Yield 0.17%

Gujarat Themis Biosyn (GUJTHEM) fundamental metrics show P/E 118.13x, P/B 4.83x, ROE 17.41%, ROCE 18.16%. Taken on their own, these numbers offer context rather than a trading signal.

Gujarat Themis Biosyn has a market capitalisation of Rs 5,066.16 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 118.13x, P/B at 4.83x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 17.41% and ROCE of 18.16%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 3.3, book value per share of Rs 80.59, dividend yield of 0.17%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 30.93x, median ROE of 10.98%, median ROCE of 12.63%. They set out the fundamental picture and are not a rating on the stock.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Pharmaceuticals & Drugs
Benchmark Scope same industry
Company P/E Ratio 118.13x
Benchmark Median P/E 30.93x
Benchmark Average P/E 52.22x
Benchmark P/E Range 2.6x to 1,177x
Company P/B Ratio 4.83x
Benchmark Median P/B 2.9x
Benchmark Average P/B 3.43x
Company ROE 17.41%
Benchmark Median ROE 10.98%
Benchmark Average ROE 4.7%
Company ROCE 18.16%
Benchmark Median ROCE 12.63%
Benchmark Average ROCE 3.14%
Company Market Capitalisation Rs 5,066.16 crore
Benchmark Median Market Cap Rs 698.04 crore
Benchmark Average Market Cap Rs 14,540.61 crore

Gujarat Themis Biosyn (GUJTHEM) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Gujarat Themis Biosyn (GUJTHEM) has a P/E ratio of 118.13x, which is above the benchmark median of 30.93x, a difference of +281.93%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Gujarat Themis Biosyn (GUJTHEM) has a ROE of 17.41%, which is above the benchmark median of 10.98%, a difference of +58.56%. Gujarat Themis Biosyn (GUJTHEM) has a ROCE of 18.16%, which is above the benchmark median of 12.63%, a difference of +43.78%.

Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Sun Pharmaceutical Industries SUNPHARMA 4,51,290.91 41.15 5.05 14.85 19.11
Divi's Laboratories DIVISLAB 3,05,014.11 90.7 16.95 16.19 21.51
Torrent Pharmaceuticals TORNTPHARM 1,77,333.2 83.49 9.65 26.76 19.27
Laurus Labs LAURUSLABS 1,30,755.56 97.59 21.57 18.31 18.2
Zydus Lifesciences ZYDUSLIFE 1,18,802.71 28.42 4.27 19.69 21.39

Gujarat Themis Biosyn (GUJTHEM) has a P/E ratio of 118.13x compared with the displayed peer median of 83.49x. The comparison is relative and should not be read as a recommendation. Its ROE of 17.41% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 18.16% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Gujarat Themis Biosyn (GUJTHEM) has a market capitalisation of Rs 5,066.16 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Gujarat Themis Biosyn

  • The Gujarat Themis Biosyn share price today is Rs 359.25, down 7.71% from the previous close of Rs 389.25.
  • The day range runs from a low of Rs 357.40 to a high of Rs 379.00.
  • The P/E ratio of 118.13 and P/B ratio of 4.83 are above the industry medians of 30.93 and 2.9.
  • ROE of 17.41% and ROCE of 18.16% are above the industry medians of 10.98% and 12.63%.
  • Market capitalisation of Rs 5,066.16 crore places the company in the Mid Cap category.

About Gujarat Themis Biosyn

Gujarat Themis Biosyn trades under the symbol GUJTHEM and operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry. According to Univest data, the company is classified as a Mid Cap business with a market capitalisation of Rs 5,066.16 crore. The Pharmaceuticals & Drugs benchmark spans 205 companies, from very small listed firms to large pharmaceutical majors such as Sun Pharmaceutical Industries and Divi’s Laboratories. Within that group, Gujarat Themis Biosyn is above the industry median market capitalisation, with its ROE and ROCE also above the industry medians.

Track Gujarat Themis Biosyn Share Price on Univest

Use Gujarat Themis Biosyn (GUJTHEM) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.

Readers can track the Gujarat Themis Biosyn share price live on Univest, along with fundamental ratios such as P/E, P/B, ROE and ROCE, 52-week levels and wider market insights. The stock page keeps the Gujarat Themis Biosyn share price update, company financials and sector benchmarks together, which makes it easier to follow how the stock compares with peers over time. Reading the Gujarat Themis Biosyn share price alongside these ratios gives a fuller picture than the daily percentage move alone.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).

Frequently Asked Questions

What is the Gujarat Themis Biosyn share price today?

Ans. The Gujarat Themis Biosyn share price today is Rs 359.25 as of 16 November 2026 at 3:07:51 PM IST. That is 7.71% below the previous close of Rs 389.25, a fall of Rs 30 per share on the day.

How much has the Gujarat Themis Biosyn share price fallen today?

Ans. The stock has fallen 7.71%, or Rs 30 per share, from the previous close of Rs 389.25. It opened at Rs 377.70, touched a high of Rs 379.00 and a low of Rs 357.40 during the day so far.

What is the market capitalisation of Gujarat Themis Biosyn?

Ans. Gujarat Themis Biosyn has a market capitalisation of Rs 5,066.16 crore and sits in the Mid Cap category. That is above the Pharmaceuticals & Drugs industry median market capitalisation of Rs 698.04 crore.

What is the P/E ratio of Gujarat Themis Biosyn?

Ans. The P/E ratio is 118.13, compared with an industry median of 30.93 and an industry average of 52.22 across 171 companies with P/E data. The P/B ratio is 4.83 against an industry median of 2.9.

What are the ROE and ROCE of Gujarat Themis Biosyn?

Ans. ROE is 17.41% and ROCE is 18.16%. Both sit above the industry medians of 10.98% and 12.63%, although the ROCE figure is lower than each of the five peers shown in the peer comparison.

What are the EPS and book value of Gujarat Themis Biosyn?

Ans. EPS is Rs 3.30 and book value per share is Rs 80.59. EPS shows earnings attributable to each share, while book value shows the accounting net worth behind each share. The dividend yield is 0.17%.

How does Gujarat Themis Biosyn compare with its peers?

Ans. Its P/E of 118.13 is higher than Sun Pharma at 41.15, Zydus Lifesciences at 28.42, Torrent at 83.49, Divi's Laboratories at 90.70 and Laurus Labs at 97.59. Its market capitalisation is also smaller than all five.

Which sector and industry does Gujarat Themis Biosyn belong to?

Ans. Gujarat Themis Biosyn belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. Univest benchmarks it against 205 companies in the same industry when comparing valuation, ROE, ROCE and market capitalisation.

What can investors monitor next for the Gujarat Themis Biosyn share price?

Ans. Investors can monitor the day range between Rs 357.40 and Rs 379.00, the P/E ratio of 118.13 against the industry median of 30.93, and the ROE and ROCE figures against peers. This is information, not a recommendation.



Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply